These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27975131)

  • 1. Impact of genetic and nongenetic factors on interindividual variability in 4β-hydroxycholesterol concentration.
    Hole K; Gjestad C; Heitmann KM; Haslemo T; Molden E; Bremer S
    Eur J Clin Pharmacol; 2017 Mar; 73(3):317-324. PubMed ID: 27975131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4β-hydroxycholesterol correlates with dose but not steady-state concentration of carbamazepine: indication of intestinal CYP3A in biomarker formation?
    Gjestad C; Huynh DK; Haslemo T; Molden E
    Br J Clin Pharmacol; 2016 Feb; 81(2):269-76. PubMed ID: 26574235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients.
    Gjestad C; Haslemo T; Andreassen OA; Molden E
    Br J Clin Pharmacol; 2017 Nov; 83(11):2398-2405. PubMed ID: 28585378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Grapefruit Juice Intake on Serum Level of the Endogenous CYP3A4 Metabolite 4β-Hydroxycholesterol-an Interaction Study in Healthy Volunteers.
    Gjestad C; Hole K; Haslemo T; Diczfalusy U; Molden E
    AAPS J; 2019 Apr; 21(4):58. PubMed ID: 31020430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation.
    Vanhove T; Hasan M; Annaert P; Oswald S; Kuypers DRJ
    Br J Clin Pharmacol; 2017 Nov; 83(11):2406-2415. PubMed ID: 28603840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians.
    Gebeyehu E; Engidawork E; Bijnsdorp A; Aminy A; Diczfalusy U; Aklillu E
    Pharmacogenomics J; 2011 Apr; 11(2):130-7. PubMed ID: 20231858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.
    Størset E; Hole K; Midtvedt K; Bergan S; Molden E; Åsberg A
    Br J Clin Pharmacol; 2017 Jul; 83(7):1457-1465. PubMed ID: 28146606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker.
    Hole K; Wollmann BM; Nguyen C; Haslemo T; Molden E
    Ther Drug Monit; 2018 Aug; 40(4):463-468. PubMed ID: 29649093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated 4β-hydroxycholesterol/cholesterol ratio in anorexia nervosa patients.
    Hole K; Heiberg PL; Gjestad C; Mehus LL; Rø Ø; Molden E
    Pharmacol Res Perspect; 2018 Oct; 6(5):e00430. PubMed ID: 30214813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.
    Eide Kvitne K; Hole K; Krogstad V; Wollmann BM; Wegler C; Johnson LK; Hertel JK; Artursson P; Karlsson C; Andersson S; Andersson TB; Sandbu R; Hjelmesæth J; Skovlund E; Christensen H; Jansson-Löfmark R; Åsberg A; Molden E; Robertsen I
    Eur J Clin Pharmacol; 2022 Aug; 78(8):1289-1299. PubMed ID: 35648149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians.
    Diczfalusy U; Miura J; Roh HK; Mirghani RA; Sayi J; Larsson H; Bodin KG; Allqvist A; Jande M; Kim JW; Aklillu E; Gustafsson LL; Bertilsson L
    Pharmacogenet Genomics; 2008 Mar; 18(3):201-8. PubMed ID: 18300941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma concentration of 4β-hydroxycholesterol with CYP3A5 polymorphism and plasma concentration of indoxyl sulfate in stable kidney transplant recipients.
    Suzuki Y; Itoh H; Fujioka T; Sato F; Kawasaki K; Sato Y; Sato Y; Ohno K; Mimata H; Kishino S
    Drug Metab Dispos; 2014 Jan; 42(1):105-10. PubMed ID: 24135442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Polymorphisms of NLRP3 Associated With Plasma Levels of 4β-Hydroxycholesterol, an Endogenous Marker of CYP3A Activity, in Patients With Asthma.
    Hirai K; Kimura T; Suzuki Y; Shimoshikiryo T; Shirai T; Itoh K
    Clin Pharmacol Ther; 2024 Jul; 116(1):147-154. PubMed ID: 38482940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of CYP3A Phenotype after Kidney Transplantation.
    Hole K; Størset E; Olastuen A; Haslemo T; Kro GB; Midtvedt K; Åsberg A; Molden E
    Drug Metab Dispos; 2017 Dec; 45(12):1260-1265. PubMed ID: 28928137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the plasma fentanyl and serum 4β-hydroxycholesterol based on CYP3A5 genotype and gender in patients with cancer pain.
    Ishida T; Naito T; Sato H; Kawakami J
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):242-8. PubMed ID: 27236640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans.
    Diczfalusy U; Nylén H; Elander P; Bertilsson L
    Br J Clin Pharmacol; 2011 Feb; 71(2):183-9. PubMed ID: 21219398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4β-Hydroxycholesterol as an endogenous biomarker of CYP3A activity in cynomolgus monkeys.
    Li K; Zhao S; Zhang L; Wu X; Shu P; Wang Y; Feng H; Gu Z; Han Hsu H
    Drug Metab Dispos; 2014 May; 42(5):839-43. PubMed ID: 24595680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4β-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State.
    Wollmann BM; Syversen SW; Lie E; Gjestad C; Mehus LL; Olsen IC; Molden E
    Clin Transl Sci; 2017 Jan; 10(1):42-49. PubMed ID: 27991741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients.
    Hoshikawa K; Naito T; Akutsu S; Saotome M; Maekawa Y; Kawakami J
    Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):353-363. PubMed ID: 31652395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.
    de Graan AJ; Sparreboom A; de Bruijn P; de Jonge E; van der Holt B; Wiemer EA; Verweij J; Mathijssen RH; van Schaik RH
    Br J Clin Pharmacol; 2015 Sep; 80(3):560-8. PubMed ID: 26119961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.